Abstract
THE problems of Hodgkin's disease and, to a lesser extent, the other malignant lymphomas have interested our group at Stanford for nearly 20 years, but systematic investigations have been undertaken only in the last 10 years. During this interval, our conception of the prognosis of Hodgkin's disease and the malignant lymphomas has undergone a dramatic change. Many physicians, myself included, were taught in medical school to believe that Hodgkin's disease is inexorably fatal and that even to think of its cure is absurd. This attitude has gradually given way in the face of recent evidence derived from investigations of the . . .